Population pharmacodynamics for monitoring epoetin in athletes

Clinical Drug Investigation

Volumn 14, Issue 3, 1997, Pages 233-242

  Bressolle, Françoise ^a   Audran, Michel ^a   Gareau, Raynald ^b   Baynes, Roy D ^c   Guidicelli, Claudette ^a   Gomeni, Roberto ^d  

^a UNIV MONTPELLIER   (France)

^b UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d BESTFIT   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; ILLICIT DRUG; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN RECEPTOR;

ADULT; AEROBIC CAPACITY; ARTICLE; ATHLETE; BLOOD SAMPLING; CAPILLARY BLOOD; CONTROLLED STUDY; DOPING; DRUG ABUSE; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MONITORING; DRUG SCREENING; ERGONOMICS; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HUMAN; HUMAN EXPERIMENT; MALE; METHODOLOGY; NORMAL HUMAN; OXYGEN TRANSPORT; PHARMACODYNAMICS; PRIORITY JOURNAL; PROBABILITY; STATISTICAL ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION; TRAINING;

EID: 0030825066     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199714030-00012     Document Type: Article

References (12)

1. Berglund B, Ekblom B. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy males. J Int Med 1991; 229: 125-30
2. Ekblom B, Berglund B. Effect of erythropoietin administration on maximal aerobic power in man. Scand J Med Sci Sports 1991; 1: 88-93
3. Kieman AT, Cowan DA. Peptides hormones and sport: misuse and detection. Br Med Bull 1992; 48 (3): 496-517
4. Koury MJ, Bondurant MC. The molecular mechanism of erythropoietin action. Eur J Biochem 1992; 210: 649-63
5. Jelkman W. Biology of erythropoietin. Clin Invest 1994; 72: S3-S10
6. Gareau R, Audran M, Baynes RD, et al. Erythropoietin abuse in athletes. Nature 1996; 380: 113
7. Souillard A, Audran M, Bressolle F, et al. Recombinant human erythropoietin and pharmacodynamic parameters in athletes. Interest of blood sampling for doping control. Br J Clin Pharmacol 1996; 42: 355-60
8. Flowers CH, Skikne BS, Covell AM, et al. The clinical measurement of serum transferrin receptor. J Lab Clin Med 1989; 114: 368-77
9. Flowers CH, Kuizon M, Beard JL, et al. A serum ferritin assay for prevalence studies of iron deficiency. Am J Hematol 1986; 23: 141-51
10. EM-fit, version 1.0, Bestfit, Luxembourg
11. Gareau R, Brisson GR, Ayotte C, et al. A possible approach to erythropoietin doping detection. In: Hemmersbach P, Birkeland KI, editors. Blood samples in doping control. Proceedings of the Second International Symposium on Drugs in Sports; 1993 Aug 29-31: Oslo, Pensumtjenest, 1994: 141-51
12. Wide L, Bengtsson C, Berglund B, et al. Detection in blood and urine of recombinant erythropoietin administered to healthy men. Med Sci Sports Exerc 1995; 27: 1569-76